Shortness of breath does not appear as a direct pharmacological side effect of Ozempic or compounded semaglutide in clinical trial data
However, using this new medication has its own set of challenges and questions
For answers to your questions, call: Why Bowel Obstruction Is Now a Warning for GLP-1 Users Peer-reviewed data linked prolonged GLP-1 exposure to measurable structural changes in the gut, including increased intestinal length and wall thickening
The C5-C6 and C6-C7 levels are most frequently affected, potentially causing arm pain, hand numbness, and grip weakness
body mass index 30, or 27 with 1 obesity-related condition (eg, hypertension, dyslipidemia) Groups: CagriSema (cagrilintide 2.4 mg + semaglutide 2.4 mg
Hypotonic solutions (too dilute) cause mucosal cells to swell